Jadine M Cehand, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- University of California, San Francisco School of Medicine, 2010
Offices
1 location · UCSF Dept of Surgery · 211 clinicians in this group
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jadine M Cehand’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$10,816
Medicare paid this office $10,816 for 60 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Biofeedback training for bowel or bladder control, initial 15 minutes | 32 | $3,000 | $30 |
| New patient visit (45+ min) | 18 | $1,828 | $102 |
| Study of rectum sensitivity and function | 26 | $1,729 | $67 |
| Biofeedback training for bowel or bladder control, each additional 15 minutes | 25 | $1,052 | $16 |
| Test for tone and sensation of rectum and anus | 27 | $955 | $35 |
See all 7 services
| Biofeedback training for bowel or bladder control, initial 15 minutes | 32 | $3,000 | $30 |
| New patient visit (45+ min) | 18 | $1,828 | $102 |
| Study of rectum sensitivity and function | 26 | $1,729 | $67 |
| Biofeedback training for bowel or bladder control, each additional 15 minutes | 25 | $1,052 | $16 |
| Test for tone and sensation of rectum and anus | 27 | $955 | $35 |
| Return visit (30+ min) | 11 | $820 | $75 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 26 | $687 | $26 |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 14 | 25 | 44 | 26 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
60 Original Medicare patients in 2024. Average age 68 · Women 82% · Also on Medicaid 40% · Health risk score 1.32. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 60% · Depression 52% · Cancer 22% · Coronary heart disease 18%.
The office billed $119,742, Medicare allowed $14,153 and paid $10,816; for 285 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 60 | 285 | 68 | 1.32 | $119,742 | $10,816 |
| 2023 | 82 | 320 | 71 | 1.47 | $145,310 | $13,893 |
| 2022 | 57 | 207 | 70 | 1.30 | $102,139 | $10,576 |
| 2021 | 67 | 304 | 72 | 1.33 | $162,681 | $18,186 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Study of rectum sensitivity and function | 48 | $3,007 | $63 |
| New patient visit (45+ min) | 29 | $2,932 | $101 |
| Biofeedback training for bowel or bladder control, initial 15 minutes | 32 | $2,736 | $32 |
| Test for tone and sensation of rectum and anus | 41 | $1,435 | $35 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 44 | $1,133 | $26 |
| Biofeedback training for bowel or bladder control, each additional 15 minutes | 25 | $931 | $18 |
2022: 8 services
| New patient visit (45+ min) | 26 | $2,663 | $102 |
| Study of rectum sensitivity and function | 31 | $1,828 | $59 |
| Biofeedback training for bowel or bladder control, initial 15 minutes | 22 | $1,537 | $31 |
| Long return visit (40+ min) | 12 | $1,337 | $111 |
| Return visit (30+ min) | 13 | $934 | $72 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 25 | $644 | $26 |
| Biofeedback training for bowel or bladder control, each additional 15 minutes | 17 | $511 | $18 |
| Test for tone and sensation of rectum and anus | 11 | $412 | $37 |
2021: 10 services
| Long return visit (40+ min) | 22 | $3,401 | $110 |
| New patient visit (60+ min) | 23 | $3,082 | $134 |
| Return visit (30+ min) | 21 | $2,829 | $76 |
| New patient visit (45+ min) | 23 | $2,287 | $99 |
| Biofeedback training for bowel or bladder control, initial 15 minutes | 24 | $1,966 | $33 |
| Study of rectum sensitivity and function | 26 | $1,776 | $68 |
| Biofeedback training for bowel or bladder control, each additional 15 minutes | 23 | $891 | $19 |
| Test for tone and sensation of rectum and anus | 14 | $531 | $38 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 14 | $397 | $28 |
| Ultrasound scan of pelvic region through rectum | 12 | $305 | $25 |
Drugs they prescribed that Part D paid
$246
Pharmacies billed $246 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 14) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
14 generic and 0 brand-name prescriptions · $246 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 14 | None | 0% (0) | 0% | $246 |
| 2020 | 39 | None | 0% (0) | None | $6,347 |
| 2019 | 57 | 17 | 0% (0) | 44% | $5,112 |
| 2018 | 22 | None | 0% (0) | 82% | $2,158 |
| 2017 | 30 | 12 | 0% (0) | 73% | $2,967 |
| 2015 | 14 | None | 0% (0) | None | $621 |
| 2013 | 13 | None | 0% (0) | None | $1,616 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Buprenorphine-Naloxone | 20 | $3,132 | $157 |
2019: 2 drugs
| Suboxone | 21 | $2,594 | $124 |
| Buprenorphine-Naloxone | 24 | $1,863 | $78 |
2018: 1 drug
| Suboxone | 14 | $1,425 | $102 |
2017: 1 drug
| Suboxone | 18 | $1,820 | $101 |
Professional record
- NPI
- 1497058010
- Licence
- CA 568285
- Trained
- University of California, San Francisco School of Medicine, 2010 · 16 years ago
- Group
- UCSF Dept of Surgery
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 1380 Howard St, 2nd Floor, San Francisco, CA, 94103
- NPI first listed
- 2010-12-21
- NPI last updated
- 2013-06-12
This is when the NPI record was last certified, not a medical board exam.